Description
Contrary is a venture capital firm that positions itself as a talent and research-driven investment firm, backing a small, selective number of entrepreneurs and the companies they build across stages from seed to scale. The firm maintains a public portfolio of its investments and operates a research arm, Contrary Research, which publishes long-form deep dives and analysis on topics ranging from biotech (e.g., rare diseases and platform biotech), defense manufacturing (e.g., missile production), anti-aging therapeutics, and industrial policy (e.g., shipbuilding). These research pieces, authored by team members such as Claire Burch and Kiran Sheth, appear to serve both as thought leadership and as a foundation for investment sourcing and diligence. The firm's clients/focus are primarily entrepreneurs and startup founders it chooses to back as portfolio companies.